However, it was shown that in the later stages of these pathologies, the blood of patients with MS and SLE contains abzymes with several different catalytic activities hydrolysing MBP, DNA, RNA, nucleotides and polysaccharides 9, 10, 11, 12, 13, 14. This evidence concerns the gene MBP and myeloid sarcoma.